logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (vi) Percentage distribution of route of administration amongst all clients with cocaine (HCl and crack) as primary drug

CountryInjectSmoke/inhaleEat/drinkSniffOthersBase (known status)Status unknown
Bulgaria0.00.00.0100.00.010
Czech Republic0.00.00.0100.00.020
Denmark6.79.83.679.90.019412
Germany28.327.81.535.86.651858124
Ireland5.87.81.385.30.04004
Greece6.832.41.459.50.0743
Spain(1)6.114.30.576.72.3197693976
France12.834.20.851.70.41309406
Italy9.746.60.441.22.1118670
Cyprus5.326.30.068.40.0570
Lithuania25.012.512.550.00.080
Luxembourg44.70.00.055.30.0380
Hungary3.316.412.368.00.01220
Malta30.912.71.852.71.8553
Netherlands(2)0.545.31.551.90.83060283
Austria14.42.64.179.00.01957
Slovakia0.028.60.071.40.071
Finland25.00.00.075.00.040
Sweden0.012.212.275.50.0492
United Kingdom(3)3.948.33.240.73.9115781581
Total8.532.21.355.22.85397414402

Notes:

 Only countries where there are clients reported with cocaine (HCl and crack) as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Thursday, 17 July 2008